New drug therapy in peripheral vascular disease

Area of Science:

• Vascular Medicine
• Pharmacology

Background:

• Peripheral vascular disease (PVD) encompasses conditions affecting circulation outside the brain and heart.
• Raynaud's phenomenon, thromboembolic disease, and intermittent claudication are significant PVD manifestations.

Purpose of the Study:

• To outline current and effective therapeutic strategies for various peripheral vascular diseases.
• To highlight pharmacological and non-pharmacological interventions for PVD management.

Main Methods:

• Review of established and emerging drug therapies for PVD.
• Evaluation of prophylactic measures for deep venous thrombosis.
• Assessment of lifestyle interventions for intermittent claudication.

Main Results:

• Nifedipine or sympathetic blocking agents are indicated for Raynaud's phenomenon.
• Low-dose warfarin is effective in preventing thromboembolic disease recurrence.
• Minidose heparin (with or without dihydroergotamine) and pneumatic boots show efficacy in deep venous thrombosis prophylaxis.
• Exercise and smoking cessation are primary treatments for intermittent claudication.

Conclusions:

• A multi-faceted approach combining pharmacotherapy and lifestyle modifications is crucial for managing peripheral vascular diseases.
• Specific treatments target distinct PVD conditions, emphasizing personalized therapeutic strategies.